Management of brain abscesses in children treated for acute lymphoblastic leukemia

Herwig Lackner1, Petra Sovinz, Martin Benesch

  • 1Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology, Medical University of Graz, Graz, Austria. herwig.lackner@meduni-graz.at

Pediatric Blood & Cancer
|November 8, 2008
PubMed

Insights

Brain abscesses in children with acute lymphoblastic leukemia (ALL) are rare but treatable. A multimodal approach combining antibiotics and hyperbaric oxygen led to survival in all four pediatric patients studied.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Neurology

Background:

  • Brain abscesses are rare, life-threatening complications in pediatric cancer patients, particularly those undergoing treatment for acute lymphoblastic leukemia (ALL).
  • Effective management strategies for these infections in severely immunocompromised hosts are critical.

Observation:

  • This study reports on four children with acute lymphoblastic leukemia (ALL) who developed brain abscesses during their cancer treatment.
  • All patients presented with neurological symptoms and confirmed brain abscesses via MRI.

Findings:

  • A multimodal treatment approach was implemented, including broad-spectrum antibiotics, liposomal amphotericin-B, and hyperbaric oxygen therapy.
  • Treatment was tailored based on isolated causative organisms.
  • All four pediatric patients survived the brain abscess, with two achieving complete resolution of neurological and MRI abnormalities.

Implications:

  • Multimodal therapy, including hyperbaric oxygen, can be a successful strategy for managing brain abscesses in immunocompromised pediatric cancer patients.
  • Early diagnosis and aggressive, tailored treatment are crucial for improving outcomes.
  • This approach offers hope for managing rare but severe infections in vulnerable pediatric populations.

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...